Clinical and Electrocardiographic Predictors of Cardiac Resynchronization Therapy Response That Correlate with the 6

Andrei Mihnea Rosu1,2, Theodor Georgian Badea2,3, Florentina Luminita Tomescu3,4

  • 1Department of Cardiology, Prof. Dr. Agripa Ionescu Emergency Hospital, 077015 Bucharest, Romania.

PubMed

Insights

The 6-minute walk test can predict cardiac resynchronization therapy outcomes. Diabetes and QRS duration impact results, suggesting QRS area and R/S ratio warrant further study for patient selection.

Area of Science:

  • Cardiology
  • Medical Technology

Background:

  • Cardiac resynchronization therapy (CRT) is vital for heart failure patients with delayed left ventricular activation.
  • Functional tests like the cardiopulmonary test and the 6-minute walk test (6MWT) assess heart failure severity.
  • The 6MWT offers a simpler, more accessible alternative for treatment adjustment.

Purpose of the Study:

  • To investigate the association between 6-minute walk test (6MWT) distance and various patient parameters.
  • To identify predictive factors for CRT outcomes.
  • To explore potential new criteria for patient selection and outcome definition in CRT.

Main Methods:

  • Prospective observational study of 69 patients.
  • Collected electrocardiographic, clinical, functional, and demographic data at baseline and 6, 9, and 12 months post-procedure.
  • Measured 6MWT distance alongside parameters like QRS area, duration, biventricular pacing percentage, systolic blood pressure, and left ventricular volume.

Main Results:

  • Diabetes and QRS duration were found to significantly impact 6-minute walk test (6MWT) distance.
  • Specific electrocardiographic parameters showed potential predictive value.

Conclusions:

  • The 6-minute walk test (6MWT) shows promise in assessing CRT outcomes.
  • Diabetes and QRS duration are key factors influencing 6MWT performance in CRT patients.
  • Further research into QRS area and R/S ratio may refine patient selection and outcome prediction for CRT.